Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation (CORE-HCT)

Peking University

Status: Enrolling

Conditions: Hematopoietic Stem Cell Transplantation; Cardiovascular Events; Transplant Complication

Study type: Observational

Funder types: Other

Identifiers

NCT07349498

2025-z232

Details and patient eligibility

About

This is a prospective, multicenter observational study for recipients of hematopoietic stem cell transplantation. Patients who underwent hematopoietic stem cell transplantation at the participating centers will be entrolled in the study. The clinical characteristics, laboratory profiles, management measures, and clinical outcomes such as post-transplant cardiovascular events will be prospectively collected.

Enrollment: 10,000 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients who undergo hematopoietic cell transplantation at any of the participating medical centers.

Exclusion criteria

• Any other conditions that, in the opinion of the investigator, can interfere with the interpretation of data.
• Patient request to withdraw from the study.

Trial design

10,000 participants in 1 patient group

Patients undergoing hematopoietic stem cell transplantation

Description:

Patients who undergo allogeneic hematopoietic stem cell transplantation at participating medical center.